Dyadic International DYAI
NASDAQ DYAI
$0.49 -0.02 (-3.66%)
As of: Sep 10, 2026 · 3:59 PM EDT

Dyadic International (DYAI) Current Assets (2017 - 2026)

Dyadic International's (DYAI) quarterly Current Assets came in at $7.7 million in Q1 2026, down 1.35% year-over-year from $7.8 million in Q1 2025, and down 22.2% quarter-over-quarter from $9.9 million in Q4 2025.

Analysis

Dyadic International (DYAI) Current Assets (2017 - 2026) Analysis & Trends

Dyadic International has disclosed Current Assets across 10 years of filings, most recently posting $7.7 million for Q1 2026.

  • In Q1 2026, Current Assets fell 1.35% year-over-year to $7.7 million; the TTM figure through Mar 2026 stood at $7.7 million (down 1.35% YoY), while the FY2025 annual figure was $9.9 million, up 0.7% from the prior year.
  • Current Assets came in at $7.7 million for Q1 2026 at Dyadic International, down from $9.9 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $16.2 billion in Q1 2022 to a low of $7.4 million in Q2 2025.
  • Average Current Assets over 5 years is $965.6 million, with a median of $10.7 million recorded in 2024.
  • Year-over-year, Current Assets jumped 57922.59% in 2022 and slumped 99.92% in 2023.
  • Over 5 years, Current Assets stood at $13.4 million in 2022, then plunged by 39.89% to $8.1 million in 2023, then rose by 21.82% to $9.8 million in 2024, then gained by 0.7% to $9.9 million in 2025, then dropped by 22.2% to $7.7 million in 2026.
  • Per Business Quant data, the three most recent Current Assets figures were $7.7 million in Q1 2026, $9.9 million in Q4 2025, and $11.5 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 34.96 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 13.95 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 12.54 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 18.45 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 8.07 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 5.82 Bn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 4.62 Bn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 7.31 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 4.74 Bn
10 Dyadic International 17.78 Mn 9.82 Mn - 7.70 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 7.70 Mn
Dec 31, 2025 9.90 Mn
Sep 30, 2025 11.55 Mn
Jun 30, 2025 7.41 Mn
Mar 31, 2025 7.81 Mn
Dec 31, 2024 9.83 Mn
Sep 30, 2024 10.69 Mn
Jun 30, 2024 10.50 Mn
Mar 31, 2024 12.54 Mn
Dec 31, 2023 8.07 Mn
Sep 30, 2023 9.09 Mn
Jun 30, 2023 11.07 Mn
Mar 31, 2023 12.81 Mn
Dec 31, 2022 13.42 Mn
Sep 30, 2022 14.93 Mn
Jun 30, 2022 16.93 Mn
Mar 31, 2022 16.24 Bn
Dec 31, 2021 21.01 Mn
Sep 30, 2021 23.57 Mn
Jun 30, 2021 26.16 Mn